Hepatology

Top Story

Hepatitis A outbreaks nearly 300% higher in recent years

May 23, 2019

Investigative NASH therapy BIO89-100 shows improved lipid profile

May 23, 2019
89bio announced positive top-line results from a phase 1 study of BIO89-100, a novel long-acting glycopegylated fibroblast growth factor 21 analogue under investigation…
Meeting News

Potentially FDA-approved medications face significant scrutiny on their printed materials

May 23, 2019
WASHINGTON — The FDA’s Office of Prescription Drug Promotion uses many methods to assess the validity of a potential medication’s print advertising…

Regulation of data privacy may affect US advancement in AI

May 23, 2019
WASHINGTON — Federal regulations regarding data privacy and collection may lead to the United States falling behind countries like China in developing artificial…
Meeting News

Uncertain future ahead for FDA without full-time commissioner

May 22, 2019
WASHINGTON — Following nearly 2 years under the leadership of Commissioner Scott Gottlieb, MD, the FDA and its Acting Commissioner Norman E. Sharpless, MD, will…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: Increased surveillance fuels hepatitis elimination in Africa

April 29, 2019
More »
Current Issues Current Issues
View the Current Issue
HCV Next